Shimpo K, Takeuchi M, Okazaki S, Kiguchi M, Hashimoto Y, Aoki Y, Kuwata M, Yamashita K
Safety Research Institute for Chemical Compounds Co., Ltd., Sapporo, Japan.
J Toxicol Sci. 1990 Jun;15 Suppl 2:11-41. doi: 10.2131/jts.15.supplementii_11.
A three-month oral subacute toxicity study of mofezolac (N-22), a non-steroidal anti-inflammatory agent, was performed using dose levels of 6, 20, 60 and 200 mg/kg in rats, and recovery was also assessed one month after withdrawal. 1. Toxic signs caused by N-22 administration, observed only in the 200 mg/kg group, were as follows: soiling around the mouth and/or nose, piloerection, anemia, diarrhea, emaciation and decreased spontaneous locomotor activity. Nine males and thirteen females in the 200 mg/kg group excreted bloody diarrhea and died of general exhaustion between weeks four and thirteen of study. 2. In the 200 mg/kg group, decrease in food consumption and suppression of body weight gain were noted in males from about week four and in females from about week six after initiation of administration, and increase in water consumption was noted in males from about week seven. 3. Urinary examination revealed a decline in urinary pH in males of the 20 mg/kg and above groups and elevation of urobilinogen levels in males of the 60 and 200 mg/kg groups. 4. Hematological examination showed decreases in erythrocyte count (RBC), hematocrit value (Ht) and hemoglobin concentration (Hb) and increase in reticulocyte rate in both sexes of the 200 mg/kg group and an increase in neutrophil rate in males of the 200 mg/kg group. 5. Biochemical examination demonstrated a decrease in chloride (Cl-) in males receiving the 20 mg/kg or above doses and a decrease in calcium (Ca++) in males of the 60 and 200 mg/kg groups. Moreover, there were decreases in cholinesterase (ChE) activity, total protein (TP) and albumin (Alb) values, as well as increases in blood urea nitrogen (BUN), uric acid (UA) and potassium (K+) in both sexes of the 200 mg/kg group, along with elevations in GOT and lactate dehydrogenase (LDH) activities in females of the 200 mg/kg group. 6. The absolute and/or relative organ weights for liver, kidneys, spleen and adrenals were increased in the 200 mg/kg group. 7. On pathological examination, perforating ulceration in the jejunum and ileum, turbid ascites, adhesion and inflammatory changes in capsules of the abdominal organs, splenomegaly, mesenteric lymph node hyperplasia and inflammatory changes in the thoracic cavity were observed in dead animals of the 200 mg/kg group. Similar pathological changes were observed in a few survival cases of the 200 mg/kg group. 8. After a one month recovery period, the above-mentioned changes had mostly recovered, indicating that they were reversible.(ABSTRACT TRUNCATED AT 250 WORDS)
对非甾体抗炎药莫非佐酯(N - 22)进行了为期三个月的大鼠口服亚急性毒性研究,给药剂量水平为6、20、60和200mg/kg,停药后一个月还评估了恢复情况。1. 仅在200mg/kg组观察到N - 22给药引起的毒性体征如下:口鼻周围弄脏、竖毛、贫血、腹泻、消瘦和自发运动活动减少。200mg/kg组的9只雄性和13只雌性在研究的第4至13周排泄血性腹泻并死于全身衰竭。2. 在200mg/kg组中,给药后约第4周雄性和第6周雌性出现食物消耗减少和体重增加受抑制,约第7周雄性出现水消耗增加。3. 尿液检查显示,20mg/kg及以上组雄性尿液pH值下降,60和200mg/kg组雄性尿胆原水平升高。4. 血液学检查显示,200mg/kg组两性的红细胞计数(RBC)、血细胞比容值(Ht)和血红蛋白浓度(Hb)降低,网织红细胞率增加,200mg/kg组雄性中性粒细胞率增加。5. 生化检查表明,接受20mg/kg及以上剂量的雄性氯化物(Cl-)降低,60和200mg/kg组雄性钙(Ca++)降低。此外,200mg/kg组两性的胆碱酯酶(ChE)活性、总蛋白(TP)和白蛋白(Alb)值降低,血尿素氮(BUN)、尿酸(UA)和钾(K+)增加,200mg/kg组雌性谷草转氨酶(GOT)和乳酸脱氢酶(LDH)活性升高。6. 200mg/kg组肝脏、肾脏、脾脏和肾上腺的绝对和/或相对器官重量增加。7. 病理检查发现,200mg/kg组死亡动物的空肠和回肠有穿孔性溃疡、浑浊腹水、腹部器官包膜粘连和炎症变化、脾肿大、肠系膜淋巴结增生以及胸腔炎症变化。200mg/kg组的一些存活病例也观察到类似的病理变化。8. 经过一个月的恢复期,上述变化大多恢复,表明它们是可逆的。(摘要截断于250字)